This resource outlines the clinical characteristics and management of valproate-induced tremors (VIT), identifying them as a common neurological side effect that typically presents as a fine postural or action-based shaking. It emphasizes the importance of patient assessment, noting that risk factors include advanced age, male gender, and a family history of essential tremors, while also highlighting the influence of drug-drug interactions and plasma protein binding. Treatment strategies focus on gradual dose reductions and optimization of formulations, with propranolol and primidone cited as primary pharmacological interventions for persistent cases.
Related resource: Lithium Induced Tremors